ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 95 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,374,000 | +64.4% | 366,401 | +16.2% | 2.07% | +38.0% |
| Q2 2022 | $1,444,000 | -42.5% | 315,301 | +8.5% | 1.50% | -18.1% |
| Q1 2022 | $2,513,000 | -18.3% | 290,501 | +34.9% | 1.83% | -3.2% |
| Q4 2021 | $3,076,000 | -34.6% | 215,401 | +0.7% | 1.89% | -39.1% |
| Q3 2021 | $4,702,000 | +9.0% | 213,901 | -33.6% | 3.10% | +9.5% |
| Q2 2021 | $4,312,000 | +11.7% | 322,249 | -15.2% | 2.83% | +4.8% |
| Q1 2021 | $3,860,000 | +57.7% | 379,944 | -34.2% | 2.70% | +38.7% |
| Q4 2020 | $2,448,000 | +62.8% | 577,317 | +0.2% | 1.95% | +29.9% |
| Q3 2020 | $1,504,000 | +3.2% | 576,317 | +39.6% | 1.50% | -5.2% |
| Q2 2020 | $1,458,000 | +1403.1% | 412,893 | +1194.3% | 1.58% | +1156.3% |
| Q1 2020 | $97,000 | -39.0% | 31,900 | +3.2% | 0.13% | -19.2% |
| Q4 2019 | $159,000 | – | 30,900 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
| Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
| Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
| Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
| Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
| Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |